Related Experiment Video
Updated: Aug 6, 2026

Modified Mouse Model of Repetitive Mild Traumatic Brain Injury Incorporating Thinned-Skull Window and Fluid Percussion
Published on: April 19, 2024
Targeting the Mechanosensitive Channel Piezo2 Alleviates Intracerebral Hemorrhage-induced Brain Injury by Modulating
Shuai Han1,2, Zirui Wang1,3, Jihu Zhao4
1The First School of Clinical Medicine, Faculty of Medicine, Yangzhou University, Anesthesiology Department, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou University, Yangzhou, 225009, PR China.
The mechanosensitive ion channel Piezo2 is upregulated in brain injury after intracerebral hemorrhage (ICH). Inhibiting Piezo2 reduces brain damage and improves cognitive function by decreasing neuronal endoplasmic reticulum stress.
Area of Science:
- Neuroscience
- Cell Biology
- Mechanobiology
Background:
- Secondary brain injury (SBI) after intracerebral hemorrhage (ICH) involves neuronal damage from mechanical forces.
- The mechanisms by which neurons sense and respond to mechanical stress are not fully understood.
Purpose of the Study:
- Investigate the role of the mechanosensitive ion channel Piezo2 in ICH-induced SBI.
- Elucidate the molecular mechanisms underlying Piezo2's involvement in neuronal damage.
Main Methods:
- Utilized a collagenase-induced ICH mouse model.
- Performed single-cell RNA sequencing to identify Piezo2 upregulation.
- Employed genetic knockdown (shRNA) and pharmacological inhibition (D-GsMTx4) of Piezo2 in vivo.
Main Results:
- Piezo2 was significantly upregulated in neurons surrounding the hematoma.
- Piezo2 inhibition alleviated acute neurological deficits, reduced brain edema, and improved long-term cognitive function.
- Inhibition of Piezo2 attenuated neuronal endoplasmic reticulum (ER) stress by downregulating the PERK/ATF4/CHOP pathway.
Conclusions:
- Piezo2 plays a critical role in mediating neuronal damage following ICH.
- Modulating Piezo2 offers a potential therapeutic strategy to mitigate secondary neurodegeneration by reducing ER stress.
- Targeting Piezo2 warrants further preclinical investigation for clinical applications in ICH treatment.

